Authors:
RIETHMULLER G
HOLZ E
SCHLIMOK G
SCHMIEGEL W
RAAB R
HOFFKEN K
GRUBER R
FUNKE I
PICHLMAIER H
HIRCHE H
BUGGISCH P
WITTE J
PICHLMAYR R
Citation: G. Riethmuller et al., MONOCLONAL-ANTIBODY THERAPY FOR RESECTED DUKES-C COLORECTAL-CANCER - 7-YEAR OUTCOME OF A MULTICENTER RANDOMIZED TRIAL, Journal of clinical oncology, 16(5), 1998, pp. 1788-1794
Authors:
HINRICHSEN H
BUGGISCH P
REISER M
SCHMIDT WE
Citation: H. Hinrichsen et al., HIGH-DOSE INTERFERON ALPHA-2A PLUS RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS-C - PRELIMINARY-RESULTS OF A MULTICENTER TRIAL, Hepatology, 28(4), 1998, pp. 2214-2214
Authors:
RUESSMANN BC
BUGGISCH P
KROGER N
FUCHS N
SCHUCH G
WACKERBACKHAUS G
RENGES H
KRUEGER W
ZANDER HAR
Citation: Bc. Ruessmann et al., HYPERBILIRUBINEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - HISTOLOGICAL-EVALUATION BY TRANSCUTAN OR TRANS-JUGULAR LIVER-BIOPSY, Bone marrow transplantation, 21, 1998, pp. 842-842
Citation: A. Deweerth et al., PANCREATICODUODENAL ARTERY ANEURYSM - A LIFE-THREATENING CAUSE OF GASTROINTESTINAL HEMORRHAGE - CASE-REPORT AND REVIEW OF THE LITERATURE, Hepato-gastroenterology, 45(23), 1998, pp. 1651-1654
Authors:
SCHMIEGEL W
SCHMIELAU J
HENNEBRUNS D
JUHL H
ROEDER C
BUGGISCH P
ONUR A
KREMER B
KALTHOFF H
JENSEN EV
Citation: W. Schmiegel et al., CYTOKINE-MEDIATED ENHANCEMENT OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION PROVIDES AN IMMUNOLOGICAL APPROACH TO THE THERAPY OF PANCREATIC-CANCER, Proceedings of the National Academy of Sciences of the United Statesof America, 94(23), 1997, pp. 12622-12626
Authors:
STERNECK M
FISCHER L
BUGGISCH P
MALAGO M
ROGIERS X
BURDELSKI M
GRETEN H
BROELSCH CE
Citation: M. Sterneck et al., TRANSPLANTATION OF COMPLETE AND SPLIT LIVER GRAFTS FOR PATIENTS WITH FULMINANT HEPATIC-FAILURE, Zeitschrift fur Gastroenterologie, 34(12), 1996, pp. 795-800
Authors:
SCHMIEGEL W
SCHMIELAU J
KESSLER A
BUGGISCH P
HENNEBRUNS D
KREMER B
JUHL H
ROEDER C
KALTHOFF H
Citation: W. Schmiegel et al., CYTOKINE-MEDIATED EGF-RECEPTOR MANIPULATION - BASICS AND THERAPEUTIC APPLICATION IN PANCREATIC-CANCER (PHASE I II CLINICAL-TRIAL)/, Gastroenterology, 110(4), 1996, pp. 429-429
Authors:
RIETHMULLER G
SCHNEIDERGADICKE E
SCHLIMOK G
SCHMIEGEL W
RAAB R
HOFFKEN K
GRUBER R
PICHLMAIER H
HIRCHE H
PICHLMAYR R
BUGGISCH P
WITTE J
EIGLER FW
FACKLERSCHWALBE I
FUNKE I
SCHMIDT CG
SCHREIBER H
SCHWEIBERER L
EIBLEIBESFELDT B
Citation: G. Riethmuller et al., RANDOMIZED TRIAL OF MONOCLONAL-ANTIBODY FOR ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA, Lancet, 343(8907), 1994, pp. 1177-1183
Authors:
KREYMANN G
GROSSER S
BUGGISCH P
GOTTSCHALL C
MATTHAEI S
GRETEN H
Citation: G. Kreymann et al., OXYGEN-CONSUMPTION AND RESTING METABOLIC-RATE IN SEPSIS, SEPSIS SYNDROME, AND SEPTIC SHOCK, Critical care medicine, 21(7), 1993, pp. 1012-1019